You Should Watch These: Intersect ENT (NASDAQ:XENT), Edison International (NYSE:EIX), WL Ross Holding Corp. (NASDAQ:WLRH), Sequenom (NASDAQ:SQNM)

West Corporation (NASDAQ:WSTC) shares moved down -3.98% in last trading session and ended the day at $21.71. WSTC Gross Margin is 57.40% and its has a return on assets of 6.80%. West Corporation (NASDAQ:WSTC) quarterly performance is 3.06%.

West Corporation (NASDAQ: WSTC) and Vidyo Inc., a leader in video collaboration, announced a strategic partnership to include integration of the VidyoWorksTM platform into the InterCall® product portfolio from West’s Unified Communications Services and various West vertical application offerings.

Intersect ENT, Inc. (NASDAQ:XENT) ended the last trading day at $16.38. Company weekly volatility is calculated as 4.92% and price to cash ratio as 3.71. Intersect ENT, Inc. (NASDAQ:XENT) showed a weekly performance of -2.44%.

Intersect ENT, Inc. (NASDAQ: XENT) announced that the company has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for the PROPEL® mini steroid releasing sinus implant to treat patients undergoing frontal sinus surgery.

On 23 March, Edison International (NYSE:EIX) shares advanced 0.89% and was closed at $71.59. EIX EPS growth in last 5 year was -2.00%. Edison International (NYSE:EIX) year to date (YTD) performance is 20.91%.

The Board of Directors of Edison International (NYSE:EIX) declared a quarterly common stock dividend of $0.48 per share, payable on April 30, 2016, to shareholders of record on March 31, 2016.

WL Ross Holding Corp. (NASDAQ:WLRH) shares remains unchanged in last trading session and ended the day at $10.03. WL Ross Holding Corp. (NASDAQ:WLRH) quarterly performance is 0.91%.

WL Ross Holdings Corp. (NASDAQ:WLRH) announced a definitive agreement to acquire Nexeo Solutions Holdings, LLC (“Nexeo Solutions” or the “Company”), a leading global distributor of chemicals and plastics and provider of environmental services, from TPG, a leading global alternative asset firm. As part of the transaction, TPG will roll over a substantial portion of its existing equity and retain approximately 35 percent ownership. The anticipated initial enterprise value, including fees and expenses, is $1,669 million, implying a multiple of 8.4x the Company’s estimated Adjusted EBITDA for the calendar year ending December 31, 2016.

Sequenom Inc. (NASDAQ:SQNM) caters to the Healthcare space. It has a net profit margin of -1.60% and weekly performance is 2.08%. On the last day of trading company shares ended up at $1.47.

Sequenom, Inc., (NASDAQ:SQNM), a life sciences company committed to enabling healthier lives through the development of innovative products and services, announced that its wholly owned subsidiary, Sequenom Laboratories™, has entered into agreements with Anthem Blue Cross and Blue Shield Health Plans for the states of Connecticut, Maine, and New Hampshire, effective March 28, 2016.